IRCT20211004052670N1
Not yet recruiting
Phase 3
The efficacy of intranasal oxytocin before applied behavior analysis (ABA) therapy of youth (4-17 years old) with autistic spectrum disorder
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 70
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •4\-17 year old
Exclusion Criteria
- •endocrine disease
- •head thruma
- •neurologic problem
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 4
Does intranasal oxytocin enhance emotions in dementia?Alzheimer's diseaseVascular dementiaNeurological - Alzheimer's diseaseNeurological - DementiasACTRN12617001531303niversity of Sydney4
Active, not recruiting
Phase 1
Oxytocin intranasal administrations in children with Prader-Willi syndrome aged from 3 to 12 years.EUCTR2016-003273-18-FRniversity Hospital of Toulouse40
Active, not recruiting
Not Applicable
Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disordersEUCTR2007-006561-32-DEWL University Hospital Bochum
Not yet recruiting
Phase 3
Evaluation of the effectiveness of oxytocin by placebo nasal spray on symptoms and treatment of adults with autismAutistic Disorder.Autistic disorderF84.0IRCT20200404046938N1Tehran University of Medical Sciences40
Completed
Phase 3
Evaluation of Intranasal oxytocine spray effect on preventing post-dural puncture headache after cesarean sectiopost-dural puncture headache.Spinal and epidural anesthesia-induced headache during the puerperiumO89.4IRCT20201215049725N1Karaj University of Medical Sciences170